SOURCE: Deep Blue, Inc.

November 16, 2006 11:20 ET

Deep Blue, Inc. Receives Letter of Interest for Initial Funding

LAS VEGAS, NV -- (MARKET WIRE) -- November 16, 2006 -- Deep Blue, Inc. (PINKSHEETS: DPBL) announces that they have received a Letter of Interest for Initial Funding in the amount ranging from $37.5 Million to a total of $52 Million from a private equity group that has demonstrated their financial capacity to complete funding.

All parties must agree upon a percentage equity stake and Deep Blue, Inc. must agree to receive partial funding initially, to allow sufficient time for the private equity group to analyze the human trial data. If the trials are successful the private equity group will fund the full amount of the project. Management believes the closing of this transaction should be completed in approximately 45 days.

Deep Blue, Inc. (www.deepblueinc.com) is bringing to market an innovative patent-pending treatment (Application Number 11/208,402) for HIV/AIDS and other viral infectious diseases.

Cautionary Statement:

This news release may contain certain forward-looking statements within the meaning of Section 27A of the Securities and Exchange Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties. Although Deep Blue, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any assumption could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included herein, the inclusion should not be regarded as a representation by Deep Blue, Inc., or any other person that the objectives and plans of Deep Blue, Inc. will be achieved.

Contact Information